The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services. It serves adult and senior cancer patients. The company operates 67 clinic locations. The Oncology Institute, Inc. was founded in 2007 and is based in Cerritos, California.
Revenue of The Oncology Institute, Inc. (TOI)
Revenue in 2023 (TTM): $324.24 M
According to The Oncology Institute, Inc.'s latest financial reports the company's current revenue (TTM) is $324.24 M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history of The Oncology Institute, Inc.
Annual Revenue
| Year | Revenue | Gross Profit | Ebitda | Income Before Tax | Net Income |
|---|---|---|---|---|---|
| 2023 | $324.24 M | $59.57 M | $-70,454,000 | $-83,104,000 | $-83,068,000 |
| 2022 | $252.48 M | $52.09 M | $8.4 M | $1.9 M | $1.66 M |
| 2021 | $203 M | $40.85 M | $-7,937,000 | $-11,598,000 | $-10,927,000 |
| 2020 | $187.51 M | $36.88 M | $-11,290,000 | $-14,814,058 | $-14,321,235 |
| 2019 | $155.41 M | $29.94 M | $307.11 K | $-2,638,127 | $-4,021,395 |
| 2018 | $113.16 M | $26.28 M | $9.08 M | $4.86 M | $3.95 M |